Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Tuberous Sclerosis × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Polycystic Ovary Syndrome 3 Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Tuberous Sclerosis 1 Thrombosis 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Perioperative Inflammatory Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Margins of Excision 1 Lymphangioleiomyomatosis 1 Long Qt Syndrome 3 1

Interventions

Everolimus 9 Sirolimus 8 ganaxolone 2 Melatonin 2 Activator Appliances 2 radiprodil 1 Vigabatrin 1 Urination 1 Simvastatin 1 Propranolol 1 Doxycycline 1 Cannabidiol 1 Calcitriol 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed

10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡